BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18753628)

  • 1. Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma.
    Qiao J; Kang J; Ishola TA; Rychahou PG; Evers BM; Chung DH
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12891-6. PubMed ID: 18753628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells.
    Ishola TA; Kang J; Qiao J; Evers BM; Chung DH
    Biochim Biophys Acta; 2007 Jun; 1770(6):927-32. PubMed ID: 17379415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAK is a critical regulator of neuroblastoma liver metastasis.
    Lee S; Qiao J; Paul P; O'Connor KL; Evers MB; Chung DH
    Oncotarget; 2012 Dec; 3(12):1576-87. PubMed ID: 23211542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas.
    Qiao J; Kang J; Cree J; Evers BM; Chung DH
    Ann Surg; 2005 May; 241(5):684-91; discussion 691-2. PubMed ID: 15849504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling.
    Paul P; Qiao J; Kim KW; Romain C; Lee S; Volny N; Mobley B; Correa H; Chung DH
    PLoS One; 2013; 8(9):e72570. PubMed ID: 24039782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt2 regulates metastatic potential in neuroblastoma.
    Qiao J; Lee S; Paul P; Qiao L; Taylor CJ; Schlegel C; Colon NC; Chung DH
    PLoS One; 2013; 8(2):e56382. PubMed ID: 23468863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
    Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
    Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of cyclin-dependent kinase inhibitors in neuroblastoma cells.
    Qiao L; Paul P; Lee S; Qiao J; Wang Y; Chung DH
    Biochem Biophys Res Commun; 2013 May; 435(2):295-9. PubMed ID: 23618860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin-releasing peptide is a growth factor for human neuroblastomas.
    Kim S; Hu W; Kelly DR; Hellmich MR; Evers BM; Chung DH
    Ann Surg; 2002 May; 235(5):621-9; discussion 629-30. PubMed ID: 11981207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bombesin induces angiogenesis and neuroblastoma growth.
    Kang J; Ishola TA; Baregamian N; Mourot JM; Rychahou PG; Evers BM; Chung DH
    Cancer Lett; 2007 Aug; 253(2):273-81. PubMed ID: 17383815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced autophagy blocks angiogenesis via degradation of gastrin-releasing peptide in neuroblastoma cells.
    Kim KW; Paul P; Qiao J; Lee S; Chung DH
    Autophagy; 2013 Oct; 9(10):1579-90. PubMed ID: 24108003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells.
    Qiao J; Kang JH; Cree J; Evers BM; Chung DH
    Neoplasia; 2007 Mar; 9(3):184-91. PubMed ID: 17401458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
    Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
    Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.
    Paul P; Gillory LA; Kang J; Qiao J; Chung DH
    Surgery; 2011 Mar; 149(3):425-32. PubMed ID: 21035156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin β1 is critical for gastrin-releasing peptide receptor-mediated neuroblastoma cell migration and invasion.
    Lee S; Qiao J; Paul P; Chung DH
    Surgery; 2013 Aug; 154(2):369-75. PubMed ID: 23889963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis.
    Qiao J; Lee S; Paul P; Theiss L; Tiao J; Qiao L; Kong A; Chung DH
    Surgery; 2013 Aug; 154(2):226-33. PubMed ID: 23806264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocytes invasiveness through activating the PI3K/AKT pathway.
    Clarimundo VS; Farinon M; Pedó RT; Teixeira VON; Nör C; Gulko PS; Xavier RM; de Oliveira PG
    Peptides; 2017 Sep; 95():57-61. PubMed ID: 28733141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma.
    Qiao J; Liu J; Jacobson JC; Clark RA; Lee S; Liu L; An Z; Zhang N; Chung DH
    PLoS One; 2022; 17(12):e0277956. PubMed ID: 36525420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.
    Hohla F; Schally AV; Kanashiro CA; Buchholz S; Baker B; Kannadka C; Moder A; Aigner E; Datz C; Halmos G
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18671-6. PubMed ID: 18003891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.